JP MORGAN/CALL/LEIDOS/135/0.1/16.08.24 Stock

Warrant

DE000JK87L26

Market Closed - Börse Stuttgart 03:48:53 2024-06-07 EDT
1.37 EUR -8.05% Intraday chart for JP MORGAN/CALL/LEIDOS/135/0.1/16.08.24
Current month-4.20%
1 month-3.52%
Date Price Change
24-06-07 1.37 -8.05%
24-06-06 1.49 +4.20%
24-06-05 1.43 -2.72%
24-06-04 1.47 -11.98%
24-06-03 1.67 +16.78%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 03:48 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying LEIDOS HOLDINGS, INC.
Issuer J.P. Morgan
WKN JK87L2
ISINDE000JK87L26
Date issued 2024-05-02
Strike 135 $
Maturity 2024-08-16 (70 Days)
Parity 10 : 1
Emission price 0.65
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.96
Lowest since issue 1.37
Delta0.7x
Omega 6.390
Premium4.2x
Gearing9.09x
Moneyness 1.073
Difference Strike -9.85 $
Difference Strike %-7.30%
Spread 0.07
Spread %4.64%
Theoretical value 1.475
Implied Volatility 39.39 %
Total Loss Probability 35.73 %
Intrinsic value 0.9119
Present value 0.5631
Break even 150.93 €
Theta-0.05x
Vega0.02x
Rho0.02x

Company Profile

Leidos Holdings, Inc. specializes in the provision of engineering, technological and scientific services. Net sales by business segment break down as follows: - defense (56.6%): design, engineering and integration of technological solutions for intelligence, airborne surveillance and reconnaissance, maritime and land-based solutions, electronic warfare systems, and automated sensor, alarm, command and control systems, software development, cyber security solutions and data processing and analysis solutions, IT infrastructure development and integration, etc.; - civil security (23.7%): development and integration of solutions for the protection of goods, data and digital information, solutions and systems for air traffic flow control and flight data management, vehicle and cargo inspection, explosives and radiation detection, computer security, environmental management, nuclear security, complex logistics management, etc.; - health (19.7%): integration of complex systems and technological infrastructures for the management of data, medical information and electronic health records, provision of healthcare services, IT systems lifecycle management, research and development of biopharmaceuticals, etc. Net sales by market are divided between the US Department of Defense and the intelligence community (49.4%), government agencies (37.4%) and commercial customers (13.2%). The United States accounts for 91,4% of net sales.
Sector
-
More about the company

Ratings for Leidos Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Leidos Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
144.8 USD
Average target price
159.2 USD
Spread / Average Target
+9.89%
Consensus